ARCHIVES

Sorafenib Targets AML Driven By Mutant FLT3 Gene

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Role, Issues In Education Considered By DRCCA Board

August 21, 1981

Reagan Signs Appropriations Bill, Vetoes Biomedical Research Authorization Measure; Capitol Hill Angry

November 16, 1984

Zometa Prevents Bone Loss In Premenopausal Women

August 29, 2008

FTC Report Disagrees With Key Provision Of Biologics Bill Backed By Companies

June 12, 2009

NCAB Hears “Impressive” Progress Reports, Including Treatment for Breast, Liver Cancer, Vaccine Studies

October 18, 1974

Philadelphia Group Begins BMT Trial for Breast Cancer

April 5, 1991